Ocular Therapeutix, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-63.4M | $-44.7M | $-39.7M | $-28.6M | $-13.3M | $-14.1M |
| Depreciation & Amortization | $1.6M | $881.0K | $754.0K | $547.0K | $404.0K | $404.0K |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $7.3M | $6.0M | $4.6M | $2.6M | $476.0K | $243.0K |
| Net Cash from Operating Activities | $-50.5M | $-34.0M | $-33.7M | $-20.5M | $-12.6M | $-12.6M |
| Investing Activities | ||||||
| Capital Expenditures | $8.3M | $1.9M | $1.8M | $1.3M | $387.0K | $203.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $27.0M | $37.1M | $-38.6M | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $32.0M | $585.0K | $65.7M | — | — | — |
| Net Change in Cash | $8.6M | $2.2M | $-6.6M | $19.9M | $-6.3M | $18.5M |
| Free Cash Flow | $-58.7M | $-35.9M | $-35.5M | $-21.8M | $-13.0M | $-12.8M |